Artificial Heart Support.
暂无分享,去创建一个
[1] C. Klersy,et al. Results with the Novacor assist system and evaluation of long-term assistance. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[2] P. Serruys,et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. , 2009, European heart journal.
[3] Bartley P Griffith,et al. LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] M. Givertz,et al. Mechanical Circulatory Support for Advanced Heart Failure: Patients and Technology in Evolution , 2012, Circulation.
[5] Adnan Kastrati,et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.
[6] Saxton Ga,et al. An ideal heart pump with hydrodynamic characteristics analogous to the mammalian heart. , 1960 .
[7] J M Fuqua,et al. First human use of the Hemopump, a catheter-mounted ventricular assist device. , 1990, The Annals of thoracic surgery.
[8] M. Slaughter,et al. Home Discharge Experience With the Thoratec TLC-II Portable Driver , 2007, ASAIO journal.
[9] T. Myers,et al. Initial experience with the Jarvik 2000 left ventricular assist system as a bridge to transplantation: report of 4 cases. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[10] D. Adams,et al. Low incidence of bleeding-related morbidity with left ventricular assist device implantation in the current era. , 2012, Artificial organs.
[11] E. Ringelstein,et al. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. , 1998, The Annals of thoracic surgery.
[12] P J Miller,et al. Evolution of the solenoid-actuated left ventricular assist system: integration with a pusher-plate pump for intra-abdominal implantation in the calf. , 1978, Artificial organs.
[13] W. Oliver. Anticoagulation and Coagulation Management for ECMO , 2009, Seminars in cardiothoracic and vascular anesthesia.
[14] F Beyersdorf,et al. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[15] A BENCINI,et al. The pneumo-massage of the heart; experimental research. , 1956, Surgery.
[16] C. Brizard,et al. Pump-induced haemolysis: a comparison of short-term ventricular assist devices , 2004, Perfusion.
[17] Denton A. Cooley,et al. Total artificial heart in two-staged cardiac transplantation. , 1981, Cardiovascular diseases.
[18] C. Hall,et al. A pseudoendocardium for implantable blood pumps. , 1966, Transactions - American Society for Artificial Internal Organs.
[19] J. R. Fitzpatrick,et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[20] F. Pagani,et al. The effectiveness of United Network of Organ Sharing status 2 transplantation in the modern era. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[21] Eisuke Tatsumi,et al. Development of a compact wearable pneumatic drive unit for a ventricular assist device , 2008, Journal of Artificial Organs.
[22] Stavros G Drakos,et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. , 2010, The American journal of cardiology.
[23] Linda Wellington,et al. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. , 2010, Interactive cardiovascular and thoracic surgery.
[24] O H Frazier,et al. The AbioCor implantable replacement heart. , 2003, The Annals of thoracic surgery.
[25] O. Frazier,et al. Clinical experience with textured blood contacting surfaces in ventricular assist devices. , 1987, ASAIO transactions.
[26] M. Morshuis,et al. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[27] R. Pierson,et al. Body Mass Index and Outcomes After Left Ventricular Assist Device Placement , 2005 .
[28] Robert L Kormos,et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[29] Å. Senning,et al. Clinical use of a cannula for left heart bypass without thoracotomy: experimental protection against fibrillation by left heart bypass. , 1962, Annals of surgery.
[30] Robert M. Adamson,et al. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience. , 2011, Journal of the American College of Cardiology.
[31] Robert L Kormos,et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[32] H. Kletschka,et al. Artificial heart. I. Application of nonpulsatile force-vortex principle. , 1968, Minnesota medicine.
[33] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[34] M C Oz,et al. Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.
[35] F. Pagani,et al. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. , 2008, Journal of the American College of Cardiology.
[36] Josef Stehlik,et al. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[37] J. Tijssen,et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience* , 2011, Critical care medicine.
[38] G. Tenderich,et al. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. , 2000, The Journal of thoracic and cardiovascular surgery.
[39] J. Copeland,et al. Orthotopic total artificial heart bridge to transplantation: preliminary results. , 1989, The Journal of heart transplantation.
[40] R K Jarvik,et al. The Jarvik 2000 Oxford system: increasing the scope of mechanical circulatory support. , 1997, The Journal of thoracic and cardiovascular surgery.
[41] J C Norman,et al. CURRENT STUDIES WITH SIMULATED NUCLEAR‐POWERED LEFT VENTRICULAR ASSIST DEVICES , 1972, Transactions - American Society for Artificial Internal Organs.
[42] F. H. van der Veen,et al. Ex Vivo Testing of Heparin-Coated Extracorporeal Circuits: Bovine Experiments , 1998, The International journal of artificial organs.
[43] D B Olsen,et al. In vivo evaluation of a peripheral vascular access axial flow blood pump. , 1988, ASAIO transactions.
[44] H. Thoma,et al. Clinical application of the ellipsoid left heart assist device. , 1978, Artificial organs.
[45] Nandini Dendukuri,et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. , 2010, Journal of the American College of Cardiology.
[46] Martin Cadeiras,et al. Device Related Infections: Are We Making Progress? , 2010, Journal of cardiac surgery.
[47] Karen Ulisney,et al. INTERMACS profiles of advanced heart failure: the current picture. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[48] P. Loyalka,et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. , 2011, Journal of the American College of Cardiology.
[49] Roland Hetzer,et al. First experiences with a novel magnetically suspended axial flow left ventricular assist device. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[50] A. Sosnowski,et al. Poly-Methyl Pentene Oxygenators Have Improved Gas Exchange Capability and Reduced Transfusion Requirements in Adult Extracorporeal Membrane Oxygenation , 2005, ASAIO journal.
[51] Wayne C Levy,et al. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[52] J. Cleveland,et al. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[53] P M Portner,et al. Isolated left ventricular assist as bridge to cardiac transplantation. , 1988, The Journal of thoracic and cardiovascular surgery.
[54] M. Slaughter,et al. Blood trauma testing of CentriMag and RotaFlow centrifugal flow devices: a pilot study. , 2012, Artificial organs.
[55] M E DeBakey,et al. Left ventricular bypass pump for cardiac assistance. Clinical experience. , 1971, The American journal of cardiology.
[56] M. Oz,et al. Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[57] S. Furukawa,et al. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation , 2005, Transplant infectious disease : an official journal of the Transplantation Society.
[58] E. Hammond,et al. Clinical use of the total artificial heart. , 1984, The New England journal of medicine.
[59] G. J. Verkerke,et al. In-vivo Evaluation of the “HIA-VAD”: a New German Ventricular Assist Device , 1994, The Thoracic and cardiovascular surgeon.
[60] M. Slaughter,et al. Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[61] S. Etoch,et al. Current status of the AbioCor implantable replacement heart. , 2001, The Annals of thoracic surgery.
[62] R. Hetzer,et al. Mechanical cardiac support in the young with the Berlin Heart EXCOR pulsatile ventricular assist device: 15 years' experience. , 2006, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.
[63] M. Slaughter,et al. 70 The HeartMate II Risk Score: Predicting Survival in Candidates for Left Ventricular Assist Device Support , 2011 .
[64] R. Hetzer,et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[65] D. Burkhoff,et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.
[66] O H Frazier,et al. Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.
[67] L. Samuels,et al. Initial experience with the Abiomed AB5000 ventricular assist device system. , 2005, The Annals of thoracic surgery.
[68] J. C. Norman,et al. TOTAL SUPPORT OF THE CIRCULATION OF A PATIENT WITH POST-CARDIOTOMY STONE-HEART SYNDROME BY A PARTIAL ARTIFICIAL HEART (ALVAD) FOR 5 DAYS FOLLOWED BY HEART AND KIDNEY TRANSPLANTATION , 1978, The Lancet.
[69] G L Hallman,et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. , 1969, The American journal of cardiology.
[70] W. Pierce,et al. Complete Left Ventricular Bypass With a Paracorporeal Pump: Design and Evaluation , 1974, Annals of surgery.
[71] Andrew Boyle,et al. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. , 2008, The Annals of thoracic surgery.
[72] C. Hall,et al. INTRAVENTRICULAR ARTIFICIAL HEART. , 1965, Transactions - American Society for Artificial Internal Organs.
[73] Marc A Simon,et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. , 2009, The Annals of thoracic surgery.
[74] D. Baran,et al. Recent improvements in outcome with the Novacor left ventricular assist device. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[75] M. Debakey,et al. Prolonged partial left ventricular bypass by means of an intrathoracic pump implanted in the left chest. , 1962, Transactions - American Society for Artificial Internal Organs.
[76] A. Anderson,et al. Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[77] Axel Haverich,et al. Waiting for a thoracic transplant in Eurotransplant * , 2006, Transplant international : official journal of the European Society for Organ Transplantation.
[78] Å. Senning,et al. Reducation of the Utilization of the Heart by Left Heart Bypass , 1962, Circulation research.
[79] Robert L Kormos,et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[80] I. Chalmers. Letter: Obstetric Delivery Today. , 1976, Lancet.
[81] William E Cohn,et al. Total Heart Replacement Using Dual Intracorporeal Continuous-Flow Pumps in a Chronic Bovine Model: A Feasibility Study , 2006, ASAIO journal.
[82] G P Noon,et al. Pulsatile Flow in Patients With a Novel Nonpulsatile Implantable Ventricular Assist Device , 2000, Circulation.
[83] D. Shavelle,et al. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock. , 2010, The Journal of invasive cardiology.
[84] C. Lafarge,et al. An Improved Blood‐Pump Interface for Left‐Ventricular Bypass , 1968, Annals of surgery.
[85] G. C. Hoffman,et al. Erythropoietin production following renal homotransplantation. , 1964, Transactions - American Society for Artificial Internal Organs.
[86] J F Antaki,et al. HeartMate II left ventricular assist system: from concept to first clinical use. , 2001, The Annals of thoracic surgery.